ELMD vs MGNX

ELMD exhibits exceptional financial health, anchored by a strong Piotroski F-Score of 8/9 and a debt-free balance sheet (Debt/Equity 0.00). While the Graham Number suggests a defensive value of $11.28, the stock's growth profile—highlighted by a very low PEG ratio of 0.35 and consistent earnings beats—justifies its current premium. With an intrinsic value of $30.39 and an analyst target of $37.00, the stock is well-positioned for further upside. The combination of high gross margins (78.23%) and strong ROE (20.20%) indicates a highly efficient business model.

MGNX exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration across all financial health dimensions. While the company shows explosive revenue growth (113% YoY) and maintains a strong liquidity position (Current Ratio 5.10), it suffers from negative gross margins and a consistent track record of missing earnings estimates. The recent 1-year price surge appears decoupled from fundamental value, as the company remains deeply unprofitable with a catastrophic ROE of -86.94%.